Innovo Research and Agilon health have announced a strategic collaboration to increase participation of independent physicians in clinical trials across the US.
The partnership will also expand Innovo’s nationwide network with independent physician groups.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Primary care physicians and specialists on the Agilon health platform provide a network that covers the Southeast, Southwest, Midwest and Northeast regions of the country.
Innovo Research would provide these practices with additional resources to further engage, educate as well as support patients care through ‘innovative’ clinical trials.
According to the National Institute on Aging, the patients participating in clinical trials will benefit from playing a more active role in their health care.
They will also benefit from receiving frequent health check-ups and more information on other support groups.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataAgilon health chief medical officer Ben Kornitzer said: “Agilon health and our physician partners are excited about this new collaboration with Innovo Research because we understand the value clinical trials can bring to our patients and physicians.
“Clinical trials move the medical community forward and offer an overwhelmingly positive experience for patients by providing access to cutting edge medical care, personalised services and support, and greater efficiency in care delivery.
“Our partners are drawn to the agilon health model because innovation and exceptional patient care is part of their DNA. Through our care platform that is 100% focused on value across the entire care continuum, our partners are in a unique position to lead and innovate.”
With the latest partnership, Agilon health’s physician practices will now enable patients to access clinical trials that are appropriate and help improve patient experience and outcomes.
